- Home
- GALT vs UHG Comparison
GALT vs UHG Comparison
Compare GALT & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- UHG
- Stock Information
- Founded
- GALT 2000
- UHG 2004
- Country
- GALT United States
- UHG United States
- Employees
- GALT N/A
- UHG N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- UHG Homebuilding
- Sector
- GALT Health Care
- UHG Consumer Discretionary
- Exchange
- GALT Nasdaq
- UHG Nasdaq
- Market Cap
- GALT 232.3M
- UHG 242.0M
- IPO Year
- GALT N/A
- UHG N/A
- Fundamental
- Price
- GALT $3.57
- UHG $3.87
- Analyst Decision
- GALT Strong Buy
- UHG
- Analyst Count
- GALT 3
- UHG 0
- Target Price
- GALT $6.00
- UHG N/A
- AVG Volume (30 Days)
- GALT 299.1K
- UHG 132.4K
- Earning Date
- GALT 08-14-2025
- UHG 08-07-2025
- Dividend Yield
- GALT N/A
- UHG N/A
- EPS Growth
- GALT N/A
- UHG N/A
- EPS
- GALT N/A
- UHG 0.10
- Revenue
- GALT N/A
- UHG $445,963,017.00
- Revenue This Year
- GALT N/A
- UHG N/A
- Revenue Next Year
- GALT N/A
- UHG N/A
- P/E Ratio
- GALT N/A
- UHG $40.51
- Revenue Growth
- GALT N/A
- UHG 7.51
- 52 Week Low
- GALT $0.73
- UHG $1.60
- 52 Week High
- GALT $4.41
- UHG $6.93
- Technical
- Relative Strength Index (RSI)
- GALT 58.06
- UHG 50.53
- Support Level
- GALT $3.55
- UHG $3.64
- Resistance Level
- GALT $3.90
- UHG $4.28
- Average True Range (ATR)
- GALT 0.32
- UHG 0.39
- MACD
- GALT -0.04
- UHG -0.05
- Stochastic Oscillator
- GALT 41.67
- UHG 30.34
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.